The Effects of Estrogen-Responsive Element- and Ligand-Induced Structural Changes on the Recruitment of Cofactors and Transcriptional Responses by ERα and ERβ

Estrogen signaling is mediated by ERα and -β. ERs are converted from an inactive form to a transcriptionally active state through conformational changes induced by ligand and estrogen-responsive element (ERE) sequences. We show here that ERα and ERβ bind to an ERE independently from ER ligands. We found that although the binding affinity of ERβ for an ERE is 2-fold lower than that of ERα, both ERs use the same nucleotides for DNA contacts. We show that both EREs and ligands are independent modulators of ER conformation. Specifically, the ERE primarily determines the receptor-DNA affinity, whereas the structure of the ER ligand dictates the affinity of ER for particular cofactors. We found that the ligand-dependent cofactor transcriptional intermediary factor-2, through a distinct surface, also interacts with ERα preferentially and independently of ligand. The extent of interaction, however, is dependent upon the ER-ERE affinity. In transfected cells, ERα is more transcriptionally active than ERβ. The ERE ...

[1]  T Nishihara,et al.  New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. , 1999, Toxicology and applied pharmacology.

[2]  F. Claessens,et al.  The AF1 and AF2 Domains of the Androgen Receptor Interact with Distinct Regions of SRC1 , 1999, Molecular and Cellular Biology.

[3]  John H. White,et al.  Different Classes of Coactivators Recognize Distinct but Overlapping Binding Sites on the Estrogen Receptor Ligand Binding Domain* , 1998, The Journal of Biological Chemistry.

[4]  J. Hayes,et al.  The missing nucleoside experiment: a new technique to study recognition of DNA by protein. , 1989, Biochemistry.

[5]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[6]  P B Sigler,et al.  Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Gorski,et al.  Marked effects of salt on estrogen receptor binding to DNA: biologically relevant discrimination between DNA sequences. , 1991, Biochemistry.

[8]  P. Chambon,et al.  Characterization of the Amino-terminal Transcriptional Activation Function of the Human Estrogen Receptor in Animal and Yeast Cells (*) , 1995, The Journal of Biological Chemistry.

[9]  J. Sumpter,et al.  Differential Effects of Xenoestrogens on Coactivator Recruitment by Estrogen Receptor (ER) α and ERβ* , 2000, The Journal of Biological Chemistry.

[10]  J. Gorski,et al.  Estrogen receptor binding to a DNA response element in vitro is not dependent upon estradiol. , 1990, Biochemistry.

[11]  M. Muyan,et al.  Fusion estrogen receptor proteins: toward the development of receptor-based agonists and antagonists , 2001, Molecular and Cellular Endocrinology.

[12]  B. Katzenellenbogen,et al.  Conformational Changes and Coactivator Recruitment by Novel Ligands for Estrogen Receptor-α and Estrogen Receptor-β: Correlations with Biological Character and Distinct Differences among SRC Coactivator Family Members. , 2000, Endocrinology.

[13]  G. Stancel,et al.  Interaction of human estrogen receptors α and β with the same naturally occurring estrogen response elements , 1999 .

[14]  E. Jensen.  Steroid Hormones, Receptors, and Antagonists , 1996, Annals of the New York Academy of Sciences.

[15]  A. Nardulli,et al.  The role of estrogen response elements in expression of the Xenopus laevis vitellogenin B1 gene. , 1992, Molecular endocrinology.

[16]  J. Schwabe,et al.  The oestrogen receptor recognizes an imperfectly palindromic response element through an alternative side-chain conformation. , 1995, Structure.

[17]  Y. Ouchi,et al.  The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. , 1998, Biochemical and biophysical research communications.

[18]  R. Lanz,et al.  Nuclear receptor coregulators: cellular and molecular biology. , 1999, Endocrine reviews.

[19]  P. Chambon,et al.  TIF2, a 160 kDa transcriptional mediator for the ligand‐dependent activation function AF‐2 of nuclear receptors. , 1996, The EMBO journal.

[20]  J. Katzenellenbogen,et al.  Analysis of the structural core of the human estrogen receptor ligand binding domain by selective proteolysis/mass spectrometric analysis. , 1995, Biochemistry.

[21]  P. Chambon,et al.  The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function , 1988, Cell.

[22]  M. Pfahl,et al.  The human estrogen receptor has transcriptional activator and repressor functions in the absence of ligand. , 1990, The New biologist.

[23]  P. Chambon,et al.  The N‐terminal part of TIF1, a putative mediator of the ligand‐dependent activation function (AF‐2) of nuclear receptors, is fused to B‐raf in the oncogenic protein T18. , 1995, The EMBO journal.

[24]  A. Traish,et al.  Binding of site-directed monoclonal antibodies to an epitope located in the A/B region (amino acids 140–154) of human estrogen receptor-induced conformational changes in an epitope in the DNA-binding domain , 1996, Steroids.

[25]  P. Chambon,et al.  Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. , 1995, Molecular endocrinology.

[26]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[27]  B. Katzenellenbogen,et al.  Transcription Activation by the Human Estrogen Receptor Subtypeβ (ERβ) Studied with ERβ and ERα Receptor Chimeras* *This work was supported by NIH Grants CA-18119 and CA-60514 (to B.S.K.). , 1998, Endocrinology.

[28]  A. Mérillat,et al.  Identification of estrogen-responsive DNA sequences by transient expression experiments in a human breast cancer cell line. , 1986, Nucleic acids research.

[29]  G. Greene,et al.  Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. , 1996, Molecular endocrinology.

[30]  I. Anderson,et al.  DNA allosterically modulates the steroid binding domain of the estrogen receptor. , 1992, The Journal of biological chemistry.

[31]  K. Glenn,et al.  Analysis of ligand dependence and hormone response element synergy in transcription by estrogen receptor , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[32]  J. Wood,et al.  Interaction of estrogen receptors α and β with estrogen response elements , 2001, Molecular and Cellular Endocrinology.

[33]  J. Gorski,et al.  Conformational and electrostatic properties of unoccupied and liganded estrogen receptors determined by aqueous two-phase partitioning. , 1985, Biochemistry.

[34]  M. Imhof,et al.  Cellular Mechanisms Which Distinguish between Hormone‐ and Antihormone‐Activated Estrogen Receptor , 1995, Annals of the New York Academy of Sciences.

[35]  M. Morrow,et al.  Tamoxifen, raloxifene, and the prevention of breast cancer. , 1999, Endocrine reviews.

[36]  B. Katzenellenbogen,et al.  Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes. , 1997, Molecular endocrinology.

[37]  A. Wolffe,et al.  Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. , 1999, Journal of molecular endocrinology.

[38]  P. Chambon,et al.  Estrogen-responsive element of the human pS2 gene is an imperfectly palindromic sequence. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[39]  D. McDonnell,et al.  The Estrogen Receptor ␤-isoform (er␤) of the Human Estrogen Receptor Modulates Er␣ Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and Antiestrogens* , 2022 .

[40]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[41]  B. Katzenellenbogen,et al.  Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Katzenellenbogen,et al.  Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. , 1996, Molecular endocrinology.

[43]  V. Giguère,et al.  Estrogen Receptor β: Re-evaluation of Estrogen and Antiestrogen Signaling , 1998, Steroids.

[44]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[45]  G. Martin,et al.  Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.

[46]  N. Grindley,et al.  The 43 residue DNA binding domain of γδ resolvase binds adjacent major and minor grooves of DNA , 1989 .

[47]  M. Tzukerman,et al.  Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. , 1994, Molecular endocrinology.

[48]  P. Chambon,et al.  Role of the two activating domains of the oestrogen receptor in the cell‐type and promoter‐context dependent agonistic activity of the anti‐oestrogen 4‐hydroxytamoxifen. , 1990, The EMBO journal.

[49]  E. Martinez,et al.  Cooperative binding of estrogen receptor to imperfect estrogen‐responsive DNA elements correlates with their synergistic hormone‐dependent enhancer activity. , 1989, The EMBO journal.

[50]  V. Giguère,et al.  Ligand-independent Activation of the Estrogen Receptors α and β by Mutations of a Conserved Tyrosine Can Be Abolished by Antiestrogens , 1998 .

[51]  J. Schwabe,et al.  Solution structure of the DNA-binding domain of the oestrogen receptor. , 1990, Nature.

[52]  John W. R. Schwabe,et al.  The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elements , 1993, Cell.

[53]  G. Greene,et al.  Human estrogen receptor bound to an estrogen response element bends DNA. , 1993, Molecular endocrinology.

[54]  P. Chambon,et al.  Mechanisms of antihormone action , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[55]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[56]  S. Inoue,et al.  Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta. , 1997, Biochemical and biophysical research communications.

[57]  B. Katzenellenbogen,et al.  Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. , 1996, Molecular endocrinology.

[58]  P. Chambon,et al.  Functional domains of the human estrogen receptor , 1987, Cell.

[59]  G. Ryffel,et al.  A 13 bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. , 1988, Nucleic acids research.

[60]  Jeffrey A. Lefstin,et al.  Allosteric effects of DNA on transcriptional regulators , 1998, Nature.

[61]  J. Gorski,et al.  High affinity binding of the estrogen receptor to a DNA response element does not require homodimer formation or estrogen. , 1993, The Journal of biological chemistry.

[62]  G. Greene,et al.  Estrogen Response Elements Function as Allosteric Modulators of Estrogen Receptor Conformation , 1998, Molecular and Cellular Biology.

[63]  B. Katzenellenbogen,et al.  Estrogen receptor activation function 1 works by binding p160 coactivator proteins. , 1998, Molecular endocrinology.

[64]  B. Katzenellenbogen,et al.  Structural analysis of covalently labeled estrogen receptors by limited proteolysis and monoclonal antibody reactivity. , 1987, Biochemistry.

[65]  E. Kalkhoven,et al.  Isoforms of steroid receptor co‐activator 1 differ in their ability to potentiate transcription by the oestrogen receptor , 1998, The EMBO journal.

[66]  B. O’Malley,et al.  Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. , 1993, Molecular endocrinology.

[67]  J. White,et al.  Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements. , 1990, The EMBO journal.

[68]  P. Meltzer,et al.  AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. , 1997, Science.

[69]  J R Wood,et al.  Allosteric modulation of estrogen receptor conformation by different estrogen response elements. , 2001, Molecular endocrinology.

[70]  P. Chambon,et al.  Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2 , 2000, EMBO reports.

[71]  M. Stallcup,et al.  GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[72]  H. Rochefort,et al.  Differential Interaction of Nuclear Receptors with the Putative Human Transcriptional Coactivator hTIF1* , 1997, The Journal of Biological Chemistry.

[73]  A. Nardulli,et al.  Estrogen Response Elements Alter Coactivator Recruitment through Allosteric Modulation of Estrogen Receptor β Conformation* , 2001, The Journal of Biological Chemistry.

[74]  G. Sathya,et al.  Sequence Requirements for Estrogen Receptor Binding to Estrogen Response Elements* , 1998, The Journal of Biological Chemistry.

[75]  D. Edwards,et al.  Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. , 1992, The Journal of biological chemistry.

[76]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.

[77]  P. Chambon,et al.  The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. , 1989, The EMBO journal.

[78]  P. Sharp,et al.  Human estrogen receptor forms multiple protein-DNA complexes. , 1990, The Journal of biological chemistry.

[79]  D. Lewis,et al.  Molecular modelling of the human estrogen receptor and ligand interactions based on site-directed mutagenesis and amino acid sequence homology , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[80]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[81]  S. Cowley,et al.  A comparison of transcriptional activation by ERα and ERβ , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[82]  J. Gustafsson,et al.  The novel estrogen receptor‐β subtype: potential role in the cell‐ and promoter‐specific actions of estrogens and anti‐estrogens , 1997, FEBS letters.

[83]  Catherine A. Royer,et al.  Quantitative characterization of the interaction between purified human estrogen receptor and DNA using fluorescence anisotropy , 2000, Nucleic Acids Res..